Using Artificial Intelligence (AI) to enhance pharmacovigilance and side-effect reporting of new drugs Oct 1, 2024 - Sep 30, 2027
The proposed PhD research will be conducted as part of the esteemed UK EPSRC funded COG-MHEAR research program, which aims to revolutionize the field of hearing assistive technology through the development of personalized multimodal solutions. This r...
Read More about Using Artificial Intelligence (AI) to enhance pharmacovigilance and side-effect reporting of new drugs.